USClinicalTrials.govClinical trialNot applicableActive, not recruiting
Adaptive Symptom Self-Management Immunotherapy Study
Official record
- Identifier
NCT05715255- Recruiting locations
country
United States- Interventions studied
- Automated Telephone Symptom Management (ATMS) and Telephone Interpersonal Counseling (TIP-C)Active control comparator
- Lead sponsor
- University of Arizona
- Target enrolment
- 400 participants
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Status
- Active, not recruiting
- First posted
- Feb 6, 2023
- Last updated on the registry
- Jul 31, 2026
- Age
- 18 Years
- Sex
- ALL
- Study contact
- No public contact is listed on the official record.
- Eligibility criteria
Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.
Inclusion Criteria: * Age 18 or older * Within 12 weeks after starting ICI treatment for cancer * Cognitively oriented to person, place and time (determined by recruiter) * Able to speak and understand English or Spanish * Access to a telephone * Severity score of 1 (mild) or higher on at least 1 of the 3 indicators of psychological distress from the PRO-CTCAE (i.e., the three items of anxious, discouraged, sad) library Exclusion Criteria: * Currently receiving regular behavioral counseling
- Indexed under
- Breast Cancer
This site does not provide medical advice
TrialBeacon only aggregates links to publicly available official information. It does not recommend, rank or evaluate any treatment, trial or medicine, and nothing here implies suitability for any individual. Please discuss anything you find with your treating doctor, and always rely on the original official page — records change over time. Full disclaimer.